VERDENCE CAPITAL ADVISORS LLC – Eli Lilly and Company Transaction History
VERDENCE CAPITAL ADVISORS LLC portfolio value:
$1.84M
portfolio value
VERDENCE CAPITAL ADVISORS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1.17% | 66 shares | 16K | $323.35 | 5.70K |
Q2 2022 | share | Decrease | -13.56% | -884 shares | -39K | $324.23 | 5.63K |
Q1 2022 | share | Increase | +17.58% | 975 shares | 335K | $286.37 | 6.52K |
Q4 2021 | share | Decrease | -0.79% | -44 shares | 240K | $277.25 | 5.54K |
Q3 2021 | share | Increase | +1.62% | 89 shares | 30K | $230.3 | 5.59K |
Q2 2021 | share | Decrease | -2.07% | -116 shares | 213K | $228.04 | 5.50K |
Q1 2021 | share | Decrease | -35.71% | -3.12K shares | -426K | $184.81 | 5.61K |
Q4 2020 | share | Decrease | -25.53% | -2.99K shares | -262K | $166.32 | 8.73K |
Q3 2020 | share | Decrease | -3.25% | -394 shares | -254K | $145.05 | 11.73K |
Q2 2020 | share | Increase | +115.90% | 6.51K shares | 1.21M | $160.1 | 12.12K |
Q1 2020 | share | Decrease | -47.91% | -5.16K shares | -638K | $134.64 | 5.61K |
Q4 2019 | share | Increase | +29.81% | 2.47K shares | 488K | $126.91 | 10.78K |
Q3 2019 | share | Increase | +44.39% | 2.55K shares | 292K | $107.36 | 8.30K |
Q2 2019 | share | Increase | +7.37% | 395 shares | -58K | $105.74 | 5.75K |
Q1 2019 | share | Increase | +2.39% | 125 shares | 89K | $123.17 | 5.35K |
Q4 2018 | share | Increase | +0.15% | 8 shares | 45K | $109.26 | 5.23K |
Q3 2018 | share | Increase | +25.39% | 1.05K shares | 205K | $100.8 | 5.22K |
Q2 2018 | share | Increase | +0.68% | 28 shares | 36K | $79.72 | 4.16K |
Q1 2018 | share | Increase | +0.34% | 14 shares | -28K | $71.78 | 4.13K |
Q4 2017 | share | Increase | 0.00% | 4.12K shares | 348K | $77.79 | 4.12K |